The WACC of OptiPharm Co Ltd (153710.KQ) is 6.6%.
| Range | Selected | |
| Cost of equity | 5.50% - 8.20% | 6.85% |
| Tax rate | 22.10% - 22.30% | 22.20% |
| Cost of debt | 5.10% - 7.00% | 6.05% |
| WACC | 5.3% - 7.8% | 6.6% |
| Category | Low | High |
| Long-term bond rate | 3.1% | 3.6% |
| Equity market risk premium | 5.8% | 6.8% |
| Adjusted beta | 0.33 | 0.53 |
| Additional risk adjustments | 0.5% | 1.0% |
| Cost of equity | 5.50% | 8.20% |
| Tax rate | 22.10% | 22.30% |
| Debt/Equity ratio | 0.14 | 0.14 |
| Cost of debt | 5.10% | 7.00% |
| After-tax WACC | 5.3% | 7.8% |
| Selected WACC | 6.6% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for 153710.KQ:
cost_of_equity (6.85%) = risk_free_rate (3.35%) + equity_risk_premium (6.30%) * adjusted_beta (0.33) + risk_adjustments (0.75%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.